Abstract Objective To examine blood concentrations of free carnitine (FC) in preterm infants with different gestational ages (GA) and birth weights (BW). Methods A total of 3 368 preterm infants were enrolled as subjects. According to GA, they were divided into extremely preterm birth (EPTB) group (GA <28 weeks; n=39), very preterm birth (VPTB) group (28 ≤ GA <32 weeks; n=405), moderately preterm birth (MPTB) group (32 ≤ GA < 34 weeks; n=507), and late preterm birth (LPTB) group (34 ≤ GA <37 weeks; n=2 417); according to BW, they were divided into extremely low birth weight (ELBW) group (BW <1 000 g; n=36), very low birth weight (VLBW) group (1 000 g ≤ BW < 1 500 g; n=387), low birth weight (LBW) group (1 500 g ≤ BW < 2 500 g; n=1 873), and normal birth weight (NBW) group (2 500 g ≤ BW <4 000 g; n=1 072). Blood concentrations of FC were measured between 72 hours and 7 days after birth. Results The EPTB and VPTB groups had significantly higher FC concentrations than the MPTB and LPTB groups (P < 0.05), and the MPTB group had significantly higher FC concentrations than the LPTB group (P < 0.05). The lower limit of the 95% medical reference range of FC increased with the reduction in GA. The ELBW and VLBW groups had significantly higher FC concentrations than the LBW and NBW groups (P < 0.05). The LBW group had significantly higher FC concentrations than the NBW group (P < 0.05). The lower limit of the 95% medical reference range of FC increased with the reduction in BW. Conclusions There is a significant increase in blood FC concentrations in very/extremely preterm infants and very/extremely low birth weight infants, and tend to decrease with the increases in GA and BW.
QI Zhi-Ye,DUAN Jiang,WANG Qiong et al. Levels of blood free carnitine in preterm infants with different gestational ages and birth weights[J]. CJCP, 2019, 21(6): 562-566.
QI Zhi-Ye,DUAN Jiang,WANG Qiong et al. Levels of blood free carnitine in preterm infants with different gestational ages and birth weights[J]. CJCP, 2019, 21(6): 562-566.
Slicker J, Vermilyea S. Pediatric parenteral nutrition:putting the microscope on macronutrients and micronutrients[J]. Nutr Clin Pract, 2009, 24(4):481-486.
Seliger G, Kantelhardt EJ, Van Der Wal C, et al. L-carnitine level in neonates - a large, retrospective analysis[J]. Arch Perinatal Med, 2007, 13:17-20.
[4]
Meyburg J, Schulze A, Kohlmueller D, et al. Acylcarnitine profiles of preterm infants over the first four weeks of life[J]. Pediatr Res, 2002, 52(5):720-723.
Clark RH, Chace DH, Spitzer AR. Impact of L-carnitine supplementation on metabolic profiles in premature infants[J]. J Perinatol, 2017, 37(5):566-571.
[10]
Crill CM, Helms RA. The use of carnitine in pediatric nutrition[J]. Nutr Clin Pract, 2007, 22(2):204-213.
[11]
Ozturk MA, Kardas Z, Kardas F, et al. Effects of L-carnitine supplementation on respiratory distress syndrome development and prognosis in premature infants:a single blind randomized controlled trial[J]. Exp Ther Med, 2016, 11(3):1123-1127.
[12]
Btaiche IF, Khalidi N. Parenteral nutrition-associated liver complications in children[J]. Pharmacotherapy, 2002, 22(2):188-211.
[13]
Bonner CM, DeBrie KL, Hug G, et al. Effects of parenteral L-carnitine supplementation on fat metabolism and nutrition in premature neonates[J]. J Pediatr, 1995, 126(2):287-292.
Whitfield J, Smith T, Sollohub H, et al. Clinical effects of L-carnitine supplementation on apnea and growth in very low birth weight infants[J]. Pediatrics, 2003, 111(3):477-482.
[17]
Seong SH, Cho SC, Park Y, et al. L-carnitine-supplemented parenteral nutrition improves fat metabolism but fails to support compensatory growth in premature Korean infants[J]. Nutr Res, 2010, 30(4):233-239.
